- May 2, 2022
- Fujifilm Selected as Platinum Partner of the National Rural Health Association
- Apr 27, 2022
- Fujifilm Awarded Pacific Air Force/Navy Order from the U.S. Department of Defense and Defense Logistics Agency for Synapse PACS
- Apr 26, 2022
-
FUJIFILM Diosynth Biotechnologies Breaks Ground on Expansion of its
BioProcess Innovation Center
- Apr 13, 2022
- Defense Logistics Agency Awards Fujifilm a Five-Year Contract to Provide Endoscopic Equipment, Technology and Training
- Apr 12, 2022
- Fujifilm Installs Synapse 7x Cardiology PACS in Emory Healthcare Facilities
- Apr 12, 2022
- Chimeron Bio Enters Into Manufacturing Agreement With FUJIFILM Diosynth Biotechnologies to Advance its RNA Oncology Candidates
- Apr 4, 2022
- Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Mar 28, 2022
- Fujifilm Completes Acquisition of Shenandoah Biotechnology
- Mar 22, 2022
-
Fujifilm to Acquire Shenandoah Biotechnology,
Leading Manufacturer of Recombinant Proteins
- Mar 17, 2022
-
FUJIFILM Diosynth Biotechnologies Gifts $200,000 to Wake Tech Foundation to Establish Early College Suite
- Mar 15, 2022
- Fujifilm Presents Award-winning Synapse Enterprise Imaging Portfolio at HIMSS 2022
- Mar 10, 2022
- Promega Corporation and FUJIFILM Cellular Dynamics Announce Strategic Collaboration to Advance Novel Assay Development
- Mar 9, 2022
- FUJIFILM Sonosite Files Patent Infringement Lawsuit Against Butterfly Network
- Mar 2, 2022
- Gastro Care Partners Taps Fujifilm to Deliver Best in Breed Endoscopic Imaging Solutions to GI Practices in Colorado
- Feb 15, 2022
- FUJIFILM Sonosite launches Sonosite LX, the industry leader’s latest premium point-of-care ultrasound system
- Feb 10, 2022
- Fujifilm launches life sciences strategic investment fund focused on emerging companies with high impact biotechnology
- Feb 10, 2022
- FUJIFILM VisualSonics and PIUR IMAGING Partner to Enable Ultra-High Frequency, 3D Ultrasound Imaging Technology
- Feb 8, 2022
- Providers Rank Fujifilm “Best in KLAS” for Three Synapse® Enterprise Imaging Solutions
- Jan 26, 2022
- Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
- Jan 6, 2022
-
FUJIFILM Cellular Dynamics and PhenoVista Biosciences Announce
Strategic Alliance to Improve the Drug Discovery Process